PFE Pfizer Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PFE

Price (delayed)

$29.01

Market cap

$165.35B

P/E Ratio

40.86

Dividend/share

$1.72

EPS

$0.71

Enterprise value

$226.2B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 46

At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes three core mechanisms of action to attack cancer ...

Highlights
The quick ratio has grown by 22% from the previous quarter and by 13% YoY
Pfizer's equity has increased by 4.5% QoQ but it has decreased by 4.1% YoY
The price to earnings (P/E) is 98% higher than the 5-year quarterly average of 21.0 and 49% higher than the last 4 quarters average of 27.8
Pfizer's net income has shrunk by 59% YoY and by 7% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.pfizer.com
Peers: MRK JNJ BMY LLY

Key stats

What are the main financial stats of PFE

PFE stock price

How has the Pfizer stock price performed over time
Intraday
-1.49%
1 week
-2.91%
1 month
2.15%
1 year
12.14%
YTD
16.51%
QTD
1.72%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$63.63B
Gross profit
$46.69B
Operating income
$4.26B
Net income
$4.04B
Gross margin
73.4%
Net margin
6.3%
PFE's net margin has plunged by 60% YoY and by 7% from the previous quarter
Pfizer's net income has shrunk by 59% YoY and by 7% QoQ
The company's operating margin has shrunk by 54% YoY
The operating income has plunged by 53% YoY

Price vs fundamentals

How does PFE's price correlate with its fundamentals

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
PFE P/E details
P/E
40.86
P/B
1.86
P/S
2.6
EV/EBIT
53.59
EV/EBITDA
21.1
EV/Sales
3.56
The price to earnings (P/E) is 98% higher than the 5-year quarterly average of 21.0 and 49% higher than the last 4 quarters average of 27.8
Pfizer's EPS has plunged by 59% YoY and by 7% from the previous quarter
PFE's P/B is 14% below its 5-year quarterly average of 2.2 but 11% above its last 4 quarters average of 1.7
Pfizer's equity has increased by 4.5% QoQ but it has decreased by 4.1% YoY
PFE's P/S is 10% above its last 4 quarters average of 2.4

Efficiency

How efficient is Pfizer business performance
The ROE has shrunk by 58% YoY and by 6% QoQ
Pfizer's ROA has plunged by 57% YoY and by 4.8% from the previous quarter
Pfizer's ROS has plunged by 55% YoY
The company's return on invested capital has shrunk by 55% YoY

Dividends

What is PFE's dividend history
Dividend details
DPS
$1.72
Dividend yield
5.93%
Payout ratio
242.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Pfizer financials performed over time
PFE's total assets is 77% greater than its total liabilities
The quick ratio has grown by 22% from the previous quarter and by 13% YoY
The current ratio has grown by 12% from the previous quarter and by 11% YoY
PFE's debt is 30% less than its equity
The debt to equity has grown by 6% YoY but it has contracted by 5% from the previous quarter
Pfizer's equity has increased by 4.5% QoQ but it has decreased by 4.1% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.